Supernus Sues Actavis, Watson Over Oxtellar XR Patents
By Kelly Knaub ( August 8, 2013, 5:35 PM EDT) -- Supernus Pharmaceuticals Inc. hit Actavis Inc. and Watson Laboratories Inc. with a lawsuit in New Jersey federal court on Wednesday alleging the drugmakers are infringing two patents covering Oxtellar XR by seeking approval to sell a generic version of the anti-epileptic drug before the patents expire....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.